Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody-Reference-Cited by-同舟云学术

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody

Published:2014-01-15 Issue:2 Volume:6 Page:422-436
ISSN:1942-0870
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Monnet Céline,Jorieux Sylvie,Souyris Nathalie,Zaki Ouafa,Jacquet Alexandra,Fournier Nathalie,Crozet Fabien,de Romeuf Christophe,Bouayadi Khalil,Urbain Rémi,Behrens Christian K,Mondon Philippe,Fontayne Alexandre

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.27854

Reference68 articles.

1. Strategies and challenges for the next generation of therapeutic antibodies

2. Optimization of Fc-mediated effector functions of monoclonal antibodies

3. The interactions of therapeutic antibodies with Fc receptors

4. Monoclonal antibodies: versatile platforms for cancer immunotherapy

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of structural modifications of IgG antibodies on effector functions;Frontiers in Immunology;2024-01-08

2. Monoclonal antibodies: recent development in drug delivery;Molecular Pharmaceutics and Nano Drug Delivery;2024

3. Analysis of the impact of handling and culture on the expansion and functionality of NK cells;Frontiers in Immunology;2023-08-11

4. The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics;Chemical Reviews;2023-05-15

5. Monoclonal antibodies in breast cancer: A critical appraisal;Critical Reviews in Oncology/Hematology;2023-03